Fig. 1From: Safety and efficacy of paclitaxel plus carboplatin versus paclitaxel plus cisplatin in neoadjuvant chemoradiotherapy for patients with locally advanced esophageal carcinoma: a retrospective studyOS (A) and PFS (B) curve of TP and TC groupBack to article page